Using digital technology for home monitoring, adherence and self-management in cystic fibrosis: a state-of-the-art review.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 31594802.
- Also identified by DOI 10.1136/thoraxjnl-2019-213233.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Digital healthcare is a rapidly growing healthcare sector. Its importance has been recognised at both national and international level, with the WHO recently publishing its first global strategy for digital health. The use of digital technology within cystic fibrosis (CF) has also increased. CF is a chronic, life-limiting condition, in which the treatment burden is high and treatment regimens are not static. Digital technologies present an opportunity to support the lives of people with CF. We included 59 articles and protocols in this state-of-the-art review, relating to 48 studies from 1999 until 2019. This provides a comprehensive overview of the expansion and evolution of the use of digital technology. Technology has been used with the aim of increasing accessibility to healthcare, earlier detection of pulmonary exacerbations and objective electronic adherence monitoring. It may also be used to promote adherence and self-management through education, treatment management Apps and social media.
Medical subject headings
- Cystic Fibrosis
- Monitoring, Ambulatory
- Patient Compliance
- Self-Management